PROCEPT BioRobotics Corporation
PRCT
$59.03
$1.412.45%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 64.84% | 71.71% | 73.74% | 83.44% | 81.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 64.84% | 71.71% | 73.74% | 83.44% | 81.55% |
| Cost of Revenue | 34.17% | 52.30% | 60.48% | 67.83% | 71.75% |
| Gross Profit | 92.96% | 89.65% | 86.48% | 99.58% | 91.58% |
| SG&A Expenses | 30.09% | 31.22% | 31.98% | 40.43% | 48.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.87% | 38.58% | 41.15% | 48.23% | 57.55% |
| Operating Income | 11.50% | -1.73% | -8.40% | -16.11% | -35.24% |
| Income Before Tax | 13.68% | 6.10% | 0.81% | -4.99% | -21.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 13.68% | 6.10% | 0.81% | -4.99% | -21.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.68% | 6.10% | 0.81% | -4.99% | -21.50% |
| EBIT | 11.50% | -1.73% | -8.40% | -16.11% | -35.24% |
| EBITDA | 13.27% | 0.13% | -6.58% | -15.16% | -35.28% |
| EPS Basic | 21.67% | 16.25% | 11.56% | 3.57% | -14.53% |
| Normalized Basic EPS | 21.66% | 13.54% | 8.71% | 0.28% | -18.94% |
| EPS Diluted | 21.67% | 16.25% | 11.56% | 3.57% | -14.53% |
| Normalized Diluted EPS | 21.66% | 13.54% | 8.71% | 0.28% | -18.94% |
| Average Basic Shares Outstanding | 10.24% | 11.96% | 12.19% | 9.10% | 6.50% |
| Average Diluted Shares Outstanding | 10.24% | 11.96% | 12.19% | 9.10% | 6.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
